NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction

Introduction and objectives The use of N-terminal pro-brain natriuretic peptide (NT-proBNP) after ST-segment elevation acute myocardial infarction (STEMI) is unclear. We evaluated its prognostic significance after post-STEMI cardiac rehabilitation. Methods The prognostic significance of NT-proBNP wa...

Descripción completa

Detalles Bibliográficos
Autores: Pérez-Solé N, De Dios E, Gavara J, Ríos-Navarro C, Marcos-Garces V, Merenciano H, Bertolín C, Climent JI, López-Bueno L, Payá A, Bonanad C, Cánoves J, Monmeneu JV, López-Lereu MP, Miñana G, De la Espriella R, Ventura A, Bayés-Genís A, Rodríguez-Capitán J, Jiménez-Navarro M, Martínez-Dolz L, Marín F, Chorro FJ, Núnez J, Sanchis J, Bodí V
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p20044
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/20044
Access Level:acceso abierto
Palabra clave:St-segment elevation myocardial infarction
N-terminal pro-brain natriuretic peptide
Cardiovascular magnetic resonance
Prognosis
Rehabilitation
id ES_9a72f5bd976ef4760e7d785c0eba37e2
oai_identifier_str oai:incliva.fundanetsuite.com:p20044
network_acronym_str ES
network_name_str España
repository_id_str
spelling NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarctionPérez-Solé NDe Dios EGavara JRíos-Navarro CMarcos-Garces VMerenciano HBertolín CCliment JILópez-Bueno LPayá ABonanad CCánoves JMonmeneu JVLópez-Lereu MPMiñana GDe la Espriella RVentura ABayés-Genís ARodríguez-Capitán JJiménez-Navarro MMartínez-Dolz LMarín FChorro FJNúnez JSanchis JBodí VSt-segment elevation myocardial infarctionN-terminal pro-brain natriuretic peptideCardiovascular magnetic resonancePrognosisRehabilitationIntroduction and objectives The use of N-terminal pro-brain natriuretic peptide (NT-proBNP) after ST-segment elevation acute myocardial infarction (STEMI) is unclear. We evaluated its prognostic significance after post-STEMI cardiac rehabilitation. Methods The prognostic significance of NT-proBNP was tested upon completion of cardiac rehabilitation (median, 45 days post-STEMI) in an exploratory group (n = 105 patients with the researchers blinded to NT-proBNP values) and validated in the following 276 patients. Baseline and cardiac imaging variables including cardiovascular magnetic resonance (CMR) parameters were recorded. The primary endpoint was the occurrence of a first major adverse cardiac event (MACE: cardiac death, myocardial infarction, or re-admission for heart failure). Results In the exploratory group, a cut-off value of NT-proBNP >400 pg/mL emerged as a potent MACE predictor (37 % vs.17 %; hazard ratio [HR]: 6.8 [1.5-30.3], p = 0.01). In the study group, during a 203-week median follow-up, 88 (32 %) first MACEs were detected. NT-proBNP >400 pg/mL (n = 168, 61 %) associated with a higher MACE rate (46 % vs. 10 %, HR: 4.6 [2.3-8.9], p < 0.001) and, separately, with more cardiac deaths, myocardial infarctions, and re-admissions for heart failure (p < 0.05 for all comparisons). NT-proBNP improved the multivariate model for MACE prediction (area under the curve 0.81 vs. 0.72, p < 0.001). Conclusions Even after comprehensive adjustment, NT-proBNP emerges as a potent, accessible and inexpensive tool for risk stratification of STEMI patients after completion of rehabilitation programs.ELSEVIER2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://incliva.portalinvestigacion.com/publicaciones/20044European Journal of Internal MedicineISSN: 09536205ISSNe: 18790828reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVAinstname:INCLIVAInglésinfo:eu-repo/semantics/openAccessoai:incliva.fundanetsuite.com:p200442026-06-07T16:35:31Z
dc.title.none.fl_str_mv NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
title NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
spellingShingle NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
Pérez-Solé N
St-segment elevation myocardial infarction
N-terminal pro-brain natriuretic peptide
Cardiovascular magnetic resonance
Prognosis
Rehabilitation
title_short NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
title_full NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
title_fullStr NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
title_full_unstemmed NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
title_sort NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction
dc.creator.none.fl_str_mv Pérez-Solé N
De Dios E
Gavara J
Ríos-Navarro C
Marcos-Garces V
Merenciano H
Bertolín C
Climent JI
López-Bueno L
Payá A
Bonanad C
Cánoves J
Monmeneu JV
López-Lereu MP
Miñana G
De la Espriella R
Ventura A
Bayés-Genís A
Rodríguez-Capitán J
Jiménez-Navarro M
Martínez-Dolz L
Marín F
Chorro FJ
Núnez J
Sanchis J
Bodí V
author Pérez-Solé N
author_facet Pérez-Solé N
De Dios E
Gavara J
Ríos-Navarro C
Marcos-Garces V
Merenciano H
Bertolín C
Climent JI
López-Bueno L
Payá A
Bonanad C
Cánoves J
Monmeneu JV
López-Lereu MP
Miñana G
De la Espriella R
Ventura A
Bayés-Genís A
Rodríguez-Capitán J
Jiménez-Navarro M
Martínez-Dolz L
Marín F
Chorro FJ
Núnez J
Sanchis J
Bodí V
author_role author
author2 De Dios E
Gavara J
Ríos-Navarro C
Marcos-Garces V
Merenciano H
Bertolín C
Climent JI
López-Bueno L
Payá A
Bonanad C
Cánoves J
Monmeneu JV
López-Lereu MP
Miñana G
De la Espriella R
Ventura A
Bayés-Genís A
Rodríguez-Capitán J
Jiménez-Navarro M
Martínez-Dolz L
Marín F
Chorro FJ
Núnez J
Sanchis J
Bodí V
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv St-segment elevation myocardial infarction
N-terminal pro-brain natriuretic peptide
Cardiovascular magnetic resonance
Prognosis
Rehabilitation
topic St-segment elevation myocardial infarction
N-terminal pro-brain natriuretic peptide
Cardiovascular magnetic resonance
Prognosis
Rehabilitation
description Introduction and objectives The use of N-terminal pro-brain natriuretic peptide (NT-proBNP) after ST-segment elevation acute myocardial infarction (STEMI) is unclear. We evaluated its prognostic significance after post-STEMI cardiac rehabilitation. Methods The prognostic significance of NT-proBNP was tested upon completion of cardiac rehabilitation (median, 45 days post-STEMI) in an exploratory group (n = 105 patients with the researchers blinded to NT-proBNP values) and validated in the following 276 patients. Baseline and cardiac imaging variables including cardiovascular magnetic resonance (CMR) parameters were recorded. The primary endpoint was the occurrence of a first major adverse cardiac event (MACE: cardiac death, myocardial infarction, or re-admission for heart failure). Results In the exploratory group, a cut-off value of NT-proBNP >400 pg/mL emerged as a potent MACE predictor (37 % vs.17 %; hazard ratio [HR]: 6.8 [1.5-30.3], p = 0.01). In the study group, during a 203-week median follow-up, 88 (32 %) first MACEs were detected. NT-proBNP >400 pg/mL (n = 168, 61 %) associated with a higher MACE rate (46 % vs. 10 %, HR: 4.6 [2.3-8.9], p < 0.001) and, separately, with more cardiac deaths, myocardial infarctions, and re-admissions for heart failure (p < 0.05 for all comparisons). NT-proBNP improved the multivariate model for MACE prediction (area under the curve 0.81 vs. 0.72, p < 0.001). Conclusions Even after comprehensive adjustment, NT-proBNP emerges as a potent, accessible and inexpensive tool for risk stratification of STEMI patients after completion of rehabilitation programs.
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://incliva.portalinvestigacion.com/publicaciones/20044
url https://incliva.portalinvestigacion.com/publicaciones/20044
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER
publisher.none.fl_str_mv ELSEVIER
dc.source.none.fl_str_mv European Journal of Internal Medicine
ISSN: 09536205
ISSNe: 18790828
reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname:INCLIVA
instname_str INCLIVA
reponame_str r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
collection r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414388182548480
score 15,812429

Similares en LA Referencia